Eupraxia Pharmaceuticals Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2017
Period Ending	Jan '25 Jan 17, 2025	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2017
Market Capitalization	165	147	79	35	-	-	Upgrade
Market Cap Growth	-32.78%	85.89%	125.87%	-	-	-	Upgrade
Enterprise Value	151	127	58	10	-	-	Upgrade
Last Close Price	4.63	5.37	3.65	2.45	-	-	Upgrade
PB Ratio	12.82	124.32	8.08	1.44	-	-	Upgrade
P/TBV Ratio	9.83	50.06	7.48	1.38	-	-	Upgrade
Debt / Equity Ratio	0.01	11.71	1.25	0.52	-0.59	-0.66	Upgrade
Quick Ratio	3.70	1.01	6.00	13.37	0.03	0.12	Upgrade
Current Ratio	4.17	1.02	6.08	13.49	0.05	0.13	Upgrade
Return on Equity (ROE)	-301.58%	-715.19%	-178.04%	-	-	-	Upgrade
Return on Assets (ROA)	-110.11%	-88.37%	-52.20%	-68.51%	-59.25%	-124.28%	Upgrade
Return on Capital (ROIC)	-128.67%	-126.40%	-58.41%	-110.75%	-	-	Upgrade
Earnings Yield	-30.15%	-25.44%	-31.75%	-86.89%	-	-	Upgrade
FCF Yield	-32.08%	-18.71%	-25.12%	-55.34%	-	-	Upgrade
Buyback Yield / Dilution	-40.29%	-25.21%	-55.45%	-102.75%	-0.01%	-0.00%	Upgrade
Total Shareholder Return	-40.29%	-25.21%	-55.45%	-102.75%	-0.01%	-0.00%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.